{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:40:50Z","timestamp":1787798450435,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1508-5","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T08:02:44Z","timestamp":1556524964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Etiology of neonatal seizures and maintenance therapy use: a 10-year retrospective study at Toulouse Children\u2019s hospital"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-5766","authenticated-orcid":false,"given":"E.","family":"Baudou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dimeglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hachon Lecamus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"1508_CR1","volume-title":"Neurology of the newborn","author":"JJ Volpe","year":"2008","unstructured":"Volpe JJ. Neurology of the newborn. 5th ed. Philadelphia: Saunders; 2008.","edition":"5"},{"key":"1508_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2009.80","volume":"5","author":"SN Rakhade","year":"2009","unstructured":"Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol. 2009;5:380\u201391.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"1508_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1046\/j.1528-1157.2001.12000.x","volume":"42","author":"RM Sanchez","year":"2001","unstructured":"Sanchez RM, Jensen FE. Maturation aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia. 2001;42(5):577\u201385.","journal-title":"Epilepsia."},{"issue":"4","key":"1508_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.siny.2013.05.008","volume":"18","author":"C Vasudevan","year":"2013","unstructured":"Vasudevan C, Levene M. Epidemiolgy and aetiology of neonatal seizures. Semin Fetal Neonatal Med. 2013;18(4):185\u201391.","journal-title":"Semin Fetal Neonatal Med"},{"key":"1508_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1212\/WNL.45.4.724","volume":"45","author":"MJ Lanska","year":"1995","unstructured":"Lanska MJ, Lanska DJ, Baumann RJ, et al. A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology. 1995;45:724\u201332.","journal-title":"Neurology."},{"key":"1508_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-3476(99)70374-4","volume":"134","author":"GM Ronen","year":"1999","unstructured":"Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr. 1999;134:71\u20135.","journal-title":"J Pediatr"},{"key":"1508_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/oxfordjournals.aje.a010079","volume":"150","author":"RM Saliba","year":"1999","unstructured":"Saliba RM, Annegers JF, Waller DK, et al. Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol. 1999;150:763\u20139.","journal-title":"Am J Epidemiol"},{"key":"1508_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/archdischild-2014-306388","volume":"100","author":"AR Hart","year":"2015","unstructured":"Hart AR, Pilling EL, Alix JJP. Neonatal seizures- part 2 : aetiology of acute symptomatic seizures, treatments and the neonatal epilepsy syndromes. Arch Dis Child Educ Pract Ed. 2015;100:226\u201332.","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"1","key":"1508_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejpn.2014.10.001","volume":"19","author":"F Pisani","year":"2015","unstructured":"Pisani F, Facini C, Pavlidis E, et al. Epilepsy after neonatal seizures : literature review. Eur J Paediatr Neurol. 2015 Jan;19(1):6\u201314.","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"1508_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2013.08.010","volume":"50","author":"A Soltirovska-Salamon","year":"2014","unstructured":"Soltirovska-Salamon A, Neubauer D, Petrovcic A, et al. Risk factors and scoring system as a prognostic tool epilepsy after neonatal seizures. Pediatr Neurol. 2014;50(1):77\u201384.","journal-title":"Pediatr Neurol"},{"key":"1508_CR11","volume-title":"Guidelines on neonatal seizures","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Guidelines on neonatal seizures. Geneva: WHO; 2011."},{"key":"1508_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pediatrneurol.2011.11.006","volume":"46","author":"HC Glass","year":"2012","unstructured":"Glass HC, Kan J, Bonifacio SL, Ferriero DM. Neonatal seizures: treatment practices among term and preterm. Pediatr Neurol. 2012;46:111\u20135.","journal-title":"Pediatr Neurol"},{"key":"1508_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejpn.2012.09.001","volume":"17","author":"R Wickstrom","year":"2013","unstructured":"Wickstrom R, Hallberg B, Bartocci M. Differing attitudes toward phenobarbital use in the neonatal period among neonatologists and child neurologists in Sweden. Eur J Paediatr Neurol. 2013;17:55\u201363.","journal-title":"Eur J Paediatr Neurol"},{"key":"1508_CR14","doi-asserted-by":"publisher","first-page":"15089","DOI":"10.1073\/pnas.222550499","volume":"99","author":"P Bittigau","year":"2002","unstructured":"Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A. 2002;99:15089\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1508_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJM199002083220604","volume":"322","author":"JR Farwell","year":"1990","unstructured":"Farwell JR, Lee JY, et al. Phenobarbital for febrile seizures effects on intelligence and on seizure recurrence. N Engl J Med. 1990;322:364\u20139.","journal-title":"N Engl J Med"},{"issue":"141","key":"1508_CR16","first-page":"706","volume":"25","author":"MR Koenigsberger","year":"1997","unstructured":"Koenigsberger MR, Caballar-Gonzaga FJ, Dierkes T. Neonatal seizures : the beginning and interruption of the treatment. Rev Neurol. 1997;25(141):706\u20138.","journal-title":"Rev Neurol"},{"key":"1508_CR17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0387-7604(83)80057-6","volume":"5","author":"P Scarpa","year":"1983","unstructured":"Scarpa P, Chierici R, Tamisari L, et al. Criteria for discontinuing neonatal seizure therapy: a long- term appraisal. Brain and Development. 1983;5:541\u20138.","journal-title":"Brain and Development"},{"key":"1508_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpeds.2016.03.035","volume":"174","author":"HC Glass","year":"2016","unstructured":"Glass HC, Shellhaas RA, Wusthoff CJ, et al. Contemporary profile of seizures in neonates : a prospective cohort study. J Pediatr. 2016;174:98\u2013103.","journal-title":"J Pediatr"},{"key":"1508_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/adc.2005.086314","volume":"93","author":"DM Murray","year":"2008","unstructured":"Murray DM, Boylan GB, Ali I, Ryan CA, Murphy BP, Connolly S. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 2008;93:187\u201391.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"5","key":"1508_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.seizure.2005.04.001","volume":"14","author":"M Mastrangelo","year":"2005","unstructured":"Mastrangelo M, Van Lierde A, Bray M, et al. Epilepstic seizures, epilepsy and epieptic syndromes in newborns : a nosological approach of 94 new cases by the 2001 proposed diagnostic scheme for people with epileptic seizures and epilepsy. Seizure. 2005;14(5):304\u201311.","journal-title":"Seizure."},{"key":"1508_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pediatrneurol.2007.04.003","volume":"37","author":"AI Bartha","year":"2007","unstructured":"Bartha AI, Shen J, Kat KH, et al. Neonatal seizures : Muticenter variability in current treatment Pratices. Pediatr Neurol. 2007;37:85\u201390.","journal-title":"Pediatr Neurol"},{"issue":"01","key":"1508_CR22","doi-asserted-by":"publisher","first-page":"031","DOI":"10.1055\/s-0038-1676035","volume":"50","author":"J. Benevent","year":"2018","unstructured":"Baudou E, Benevent J, Montastruc JL, Touati G. Hachon LeCamus C. adverse effects of treatment with Valproic acid during the neonatal period. Neuropediatrics. 2018. \n                    https:\/\/doi.org\/10.1055\/s-0038-1676035.","journal-title":"Neuropediatrics"},{"key":"1508_CR23","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/088307389601100506","volume":"11","author":"B Singh","year":"1996","unstructured":"Singh B, Singh P, Al Hifzi I, et al. Treatment of neonatal seizures with carbamazepine. J Child Neurol. 1996;11:378\u201382.","journal-title":"J Child Neurol"},{"key":"1508_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s004310100760","volume":"160","author":"T Hoppen","year":"2001","unstructured":"Hoppen T, ErichElger C, Bartmann P. Carbamazepine in phenobarbital-non responders: experience with ten preterm infants. Eur J Pediatr. 2001;160:444\u20137.","journal-title":"Eur J Pediatr"},{"issue":"11","key":"1508_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1177\/0883073813480241","volume":"28","author":"A Weinstock","year":"2013","unstructured":"Weinstock A, Ruiz M, Gerard D, Toublanc N, Stockis A, Farooq O, et al. Prospective open-label, single-arm, multicenter, safety, tolerability, and pharmacokinetic studies of intravenous levetiracetam in children with epilepsy. J Child Neurol. 2013 Nov;28(11):1423\u20139.","journal-title":"J Child Neurol"},{"key":"1508_CR26","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","volume":"66","author":"TA Glauser","year":"2006","unstructured":"Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology. 2006;66:1654\u201360.","journal-title":"Neurology"},{"key":"1508_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pediatrneurol.2010.11.005","volume":"44","author":"O Khan","year":"2011","unstructured":"Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B. Use of intravenous levetiracetam for management of acute seizures in neonates. Pediatr Neurol. 2011;44:265\u20139.","journal-title":"Pediatr Neurol"},{"key":"1508_CR28","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jocn.2012.08.014","volume":"20","author":"A Rakshasbhuvankar","year":"2013","unstructured":"Rakshasbhuvankar A, Rao S, Kohan R, Simmer K, Nagarajan L. Intravenous levetiracetam for treatment of neonatal seizures. J Clin Neurosci. 2013;20:1165\u20137.","journal-title":"J Clin Neurosci"},{"key":"1508_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1177\/0883073810384263","volume":"26","author":"NS Abend","year":"2011","unstructured":"Abend NS, Gutierrez-Colina AM, Monk HM, Dlugos DJ, Clancy RR. Levetiracetam for treatment of neonatal seizures. J Child Neurol. 2011;26:465\u201370.","journal-title":"J Child Neurol"},{"issue":"1","key":"1508_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpn.2010.10.003","volume":"15","author":"G Ramantani","year":"2011","unstructured":"Ramantani G, Ikonomidou C, Walter B, et al. Levetiracetam: safety and efficacy in neonatal seizures. Eur J Paediatr Neurol. 2011;15(1):1\u20137.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1508_CR31","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/S0387-7604(86)80082-1","volume":"8","author":"A Steinberg","year":"1986","unstructured":"Steinberg A, Shalev R, Amir N. Valproic acid in neonatal status convulsivus. Brain Dev. 1986;8(3):278\u2013820.","journal-title":"Brain Dev"},{"issue":"12","key":"1508_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1177\/088307380001501216","volume":"15","author":"I Alfonso","year":"2000","unstructured":"Alfonso I, Alvarez LA, Dunoyer C, Yelin K, Papazian O. Intravenous valproate dosing in neonates. J Child Neurol. 2000;15(12):827\u20139.","journal-title":"J Child Neurol"},{"issue":"3","key":"1508_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1212\/WNL.38.3.467","volume":"38","author":"P Gal","year":"1988","unstructured":"Gal P, Oles KS, Gilman JT, Weaver R. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures. Neurology. 1988;38(3):467\u201371.","journal-title":"Neurology."},{"issue":"4","key":"1508_CR34","first-page":"317","volume":"2","author":"JM Irvine-Meek","year":"1982","unstructured":"Irvine-Meek JM, Hall KW, Otten NH, et al. Pharmacokinetic study of valproic acid in a neonate. Pediatr Pharmacol. 1982;2(4):317\u201321.","journal-title":"Pediatr Pharmacol"},{"key":"1508_CR35","doi-asserted-by":"publisher","first-page":"43S","DOI":"10.1111\/j.1365-2125.1989.tb03460.x","volume":"27","author":"D Graham","year":"1989","unstructured":"Graham D. Neuropathology of vigabatrin. Br J Clin Pharmac. 1989;27:43S\u20135S.","journal-title":"Br J Clin Pharmac"},{"key":"1508_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/019262338701500203","volume":"15","author":"WH Butler","year":"1987","unstructured":"Butler WH, Ford GP, Newberne JW. A study of the effects of vigabatrin on the central nervous system and retina of Sprague Dawley and Lister-hooded rats. Toxicol Pathol. 1987;15:143\u20138.","journal-title":"Toxicol Pathol"},{"key":"1508_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/bmj.314.7075.180","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Talbot JF, Lawden MC. Severe persistent visual field constriction associated with vigabatrin. BMJ. 1997;314:180.","journal-title":"BMJ"},{"issue":"12","key":"1508_CR38","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1111\/j.1528-1167.2010.02772.x","volume":"51","author":"MJ Maguire","year":"2010","unstructured":"Maguire MJ, Hemming K, Wild JM, et al. Prevalence of visual fiels loss following exposure to vigabatrin therapy: a systematic review. Epilepsia. 2010;51(12):2123\u201331.","journal-title":"Epilepsia."},{"issue":"1","key":"1508_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jfo.2008.11.008","volume":"32","author":"I. Ingster-Moati","year":"2009","unstructured":"Ingster-Moati I, Orssaud C. Protocole de surveillance ophtalmologique des patients traites par antipaludeens de synthese ou par vigabatrin au long cours. Journal francais d\u2019ophtalmologie 2009 ;32 :83\u201388.","journal-title":"Journal Fran\u00e7ais d'Ophtalmologie"},{"key":"1508_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1059-1311(05)80080-9","volume":"4","author":"PS Baxter","year":"1995","unstructured":"Baxter PS, Gardner-Medwin D, Barwick DD, et al. Vigabatrin monotherapy in resistant neonatal seizures. Seizure. 1995;4:57\u20139.","journal-title":"Seizure"},{"key":"1508_CR41","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1046\/j.1365-2125.1996.00495.x","volume":"42","author":"F Vauzelle-Kervroidan","year":"1996","unstructured":"Vauzelle-Kervroidan F, Rey E, Pons G, et al. Pharmacokinetics of the inidvidual enantiomers of vigabatrin in neonates with uncontrolled seizures. Br J Clin Pharmacol. 1996;42:779\u201381.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"1508_CR42","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/epi.12984","volume":"56","author":"T Pisano","year":"2015","unstructured":"Pisano T, Numis AL, Heavin SB, et al. Early effective treatment of KCNQ2 encephalopathy. Epilepsia. 2015;56(5):685\u201391.","journal-title":"Epilepsia"},{"issue":"12","key":"1508_CR43","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1111\/epi.13596","volume":"57","author":"TT Sands","year":"2016","unstructured":"Sands TT, Balestri M, Bellini G, et al. Rapid and safe response to low-dose carbamazepine in neonatal epilepsy. Epilepsia. 2016 Dec;57(12):2019\u201330.","journal-title":"Epilepsia"},{"issue":"4","key":"1508_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.braindev.2016.10.015","volume":"39","author":"R Dilena","year":"2017","unstructured":"Dilena R, Striano P, Gennaro E, et al. Efficacy of sodium channel blockers in SCN2A early infantile epileptic encephalopathy. Brain and Development. 2017 Apr;39(4):345\u20138.","journal-title":"Brain and Development"},{"issue":"9","key":"1508_CR45","doi-asserted-by":"publisher","first-page":"9S46","DOI":"10.1016\/S0929-693X(17)30331-7","volume":"24","author":"O. Baud","year":"2017","unstructured":"Baud O, Auvin S, Saliba E et al. Prise en charge th\u00e9rapeutique des convulsions associ\u00e9es \u00e0 l\u2019accident vasculaire c\u00e9r\u00e9bral du nouveau-n\u00e9 et perspectives de neuroprotection \u00e0 la phase aigu\u00eb. Arch Pediatr 2017;24(9) :9S46-9S50.","journal-title":"Archives de P\u00e9diatrie"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1508-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1508-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:04:31Z","timestamp":1588028671000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1508-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1508"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1508-5","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Retrospectively registered. Patient data were reported to the \u201cCommission Nationale Informatique et Libert\u00e9s\u201d under the number 2106953. Non-opposition verbal consent was obtained from the parents of the subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"136"}}